Perinatal Infections Market

Home Healthcare And Pharmaceutical Perinatal Infections Market

SPECIAL OFFER : 25% Super Discount For All !

Perinatal Infections Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Infection (Cytomegalovirus Infection, Enterovirus Infection, Genital Herpes, Gonorrhoea, Human Immunodeficiency Virus, Others); By Diagnosis (Maternal Test, Neonatal Test, Others); By Treatment (Antibiotics, Antiviral, Antiretroviral, Others); By Route of Administration (Oral, Parenteral, Others); By End User (Hospitals, Homecare, Specialty Clinics, Others); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

Published Date: April 2023
Report ID: BWC23333
Available Format: PDF
Page: 400

Report Overview

Increasing cases of HIV and increasing incidence of perinatal infections are expected to boost the growth of global perinatal infections market during the forecast period between 2023 and 2029

Global Perinatal Infections Market - Industry Trends & Forecast Report, 2029

Global perinatal infections market size is projected to grow at a CAGR of 7.30% during the forecast period between 2023 and 2029. Major growth factors for the global perinatal infections market include a high birth rate and rising annual birth rate, as well as unhygienic conditions around people giving birth, especially in underdeveloped nations. The increasing number of premature deliveries is emerging as the major cause of perinatal infections, which is anticipated to drive market growth during the forecast period.

Global Perinatal Infections Market – Overview

Perinatal infections are infections that can be passed from the person giving birth to the newborn during pregnancy, childbirth, or the first few hours following birth. Because newborns, especially those born preterm, have a limited capacity for symptom expression, even little variations from the norm should be taken as a sign of bacterial illness. Infections like the flu, vaginal yeast infections, dermatitis, herpes, uterine infections, group B streptococcus (GBS), bacterial vaginosis (BV), and listeria are frequently seen during pregnancy.

Global Perinatal Infections Market

Growth Drivers

Increasing Cases of Perinatal Infections and Neonatal Mortality

According to research published by the National Center for Biotechnology Information, 10.7% of all maternal fatalities worldwide are caused by direct maternal infections. 98% of neonatal deaths occur in low- and middle-income countries (LMIC), with South Asia and sub-Saharan Africa, accounting for 79% of these deaths. Over one-third of neonatal deaths occur during the first day of life and around two-thirds within the first week. Neonatal sepsis is a significant contributor to infant morbidity and mortality, accounting for at least one-third of those fatalities. Despite a global decrease in newborn mortality of 20 fatalities per 1000 live births between 1990 and 2019, the burden of infection-related neonatal mortality did not considerably decrease over that time, which is expected to fuel the growth of global perinatal infections market during the forecast period.

Restraints

Lack of Skilled Professionals

The expansion of the global perinatal infections market during the forecast period may be restrained by a lack of skilled professionals who are able to treat patients with the proper treatments.

Impact of COVID-19 on Global Perinatal Infections Market

According to research published in the National Center for Biotechnology Information, no specific or convincing evidence exists to support the notion that SARS-CoV and MERS-CoV are vertically transmitted. Similarly, there is not enough evidence at this time to demonstrate that COVID-19 is transmitted vertically. However, a newborn delivered to a pregnant person who had COVID-19 was said to have higher IgM antibody levels to SARS-CoV-2 in blood two hours after delivery, indicating that COVID-19 may have the potential for vertical transmission. This resulted in significant growth in the overall global perinatal infections market.

Global Perinatal Infections Market

Segmental Coverage

Global Perinatal Infections Market – By Infection

Based on infection, the global perinatal infections market is divided into cytomegalovirus infection, enterovirus infection, genital herpes, gonorrhea, human immunodeficiency virus, and other segments. The human immunodeficiency virus (HIV) segment accounts for the highest market share. The HIV transmission from mother to newborn is a worldwide issue. About 7% to 40% of babies with HIV-positive mothers develop the disease. These newborns have a dismal prognosis, as the majority suffer diseases that advance quickly and early in life.

Global Perinatal Infections Market – By Diagnosis

Based on the diagnosis, the global perinatal infections market is segmented into the maternal test, neonatal tests, and others. The maternal test accounts for the highest share of the global perinatal infections market. Little to no immunity exists in the embryo and fetus, therefore they are immune and dependent on their mother. Numerous diseases have the ability to pass through the placenta and infect the fetus. Because bacteria that cause mild illnesses in pregnant people can be extremely hazardous to the growing embryo or baby, pregnant people frequently undergo diagnosis to detect any form of infection.

Global Perinatal Infections Market – By Treatment

Based on treatment, the global perinatal infections market is segmented into antibiotics, antiviral, antiretroviral, and others. The antibiotics treatment accounts for the highest market share. Prompt empiric antibiotic therapy with medications like ampicillin and gentamicin or ampicillin and cefotaxime is the main treatment for suspected bacterial infection in the newborn.

Global Perinatal Infections Market – By Route of Administration

Based on the route of administration, the global perinatal infections market is segmented into oral, parenteral, and others. The parenteral route of administration holds the highest share of the global perinatal infections market. Parenteral medication delivery has a quicker and more controlled bioavailability. Parenteral drug delivery avoids interference from liver metabolism for the medicine. The low concentration of medicine required by this route and the lack of risk of drug degradation by digestive fluids all help to fuel the market expansion for this route.

Perinatal Infections Market Size

Global Perinatal Infections Market – By End User

Based on end user, global perinatal infections market is segmented into hospitals, homecare, specialty clinics, and others. The hospital segment accounts for the highest market share, as hospitals are considered the safest settings for delivery. According to the National Academics, a vast majority of Americans, around 98.4%, give birth in a hospital, which contributes to the segment’s growth. However, homecare and specialty clinics are also projected to register a high growth rate during the forecast period owing to the growing number of pregnant people opting to give birth outside of hospitals, either at home or in specialized birthing facilities known as birth centers.

Global Perinatal Infections Market – By Region

The in-depth research report on the global perinatal infections market covers the markets in various countries across five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The Middle East and Africa region dominates the global perinatal infections market. According to a research published by National Center for Biotechnology Information, 98% of newborn deaths occur in low- and middle-income countries (LMIC), 79% of which take place in South Asia and sub-Saharan Africa, among which at least one-third of those fatalities are connected to infection and Neonatal sepsis is a significant contributor to infant morbidity and mortality.

Competitive Landscape

Major players operating in the global Perinatal Infections market include Merck KGaA, Beckman Coulter Inc., BIOMERIEUX, Bio-Rad Laboratories, Inc, Danaher, Hologic Inc., Gilead Sciences, Inc., Emcure Pharmaceuticals Limited., Cipla Inc., Hetero, Bausch Health Companies Inc., Johnson & Johnson Private Limited, Mylan N.V., Teva Pharmaceutical Industries Ltd, Sanofi, Novartis AG, and Sun Pharmaceutical Industries Ltd.

To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Scope of the Report

Attributes	Details
Years Considered	Historical Data – 2019–2022
	Base Year – 2022
	Estimated Year – 2023
	Forecast Period – 2023–2029
Facts Covered	Revenue in USD million
Market Coverage	North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Product/ Service Segmentation	Infection, Diagnosis, Treatment, Route of Administration, End User, Region
Key Players	Merck KGaA, Beckman Coulter Inc., BIOMERIEUX, Bio-Rad Laboratories, Inc, Danaher, Hologic Inc., Gilead Sciences, Inc., Emcure Pharmaceuticals Limited., Cipla Inc., Hetero, Bausch Health Companies Inc., Johnson & Johnson Private Limited, Mylan N.V., Teva Pharmaceutical Industries Ltd., Sanofi, Novartis AG, Sun Pharmaceutical Industries Ltd

By Infection

Cytomegalovirus Infection
Enterovirus Infection
Genital Herpes
Gonorrhoea
Human Immunodeficiency Virus
Others

By Diagnosis

Maternal Test
Neonatal Test
Others

By Treatment

Antibiotics
Antiviral
Antiretroviral
Others

By Route of Administration

Oral
Parenteral
Others

By End User

Hospitals
Homecare
Specialty Clinics
Others

By Region

North America
Europe
Asia Pacific (APAC)
Latin America
Middle East and Africa (MEA)

Research Framework
1. Research Objective
2. Infection Overview
3. Market Segmentation
Executive Summary
Global Perinatal Infections Market Insights
1. Industry Value Chain Analysis
  1. DROC Analysis
  2. Growth Drivers
    1. Increased Cases of HIV
    2. Increasing Incidence of Perinatal Infections
  3. Restraints
    1. Lack of skilled professionals
  4. Opportunities
    1. Increasing Demand for Retail Pharmacies
  5. Challenges
    1. High Cost Involved in Treatment
2. Technological Advancement/Recent Developments
3. Regulatory Framework
4. Porter’s Five Forces Analysis
  1. Bargaining Power of Suppliers
  2. Bargaining Power of Buyers
  3. Threat of New Entrants
  4. Threat of Substitutes
  5. Intensity of Rivalry
Global Perinatal Infections Market Overview
1. Market Size & Forecast, 2019–2029
  1. By Value (USD Million)
2. Market Share & Forecast
  1. By Infection
    1. Cytomegalovirus Infection
    2. Enterovirus Infection
    3. Genital Herpes
    4. Gonorrhoea
    5. Human Immunodeficiency Virus
    6. Others
  2. By Diagnosis
    1. Maternal Test
    2. Neonatal Test
    3. Others
  3. By Treatment
    1. Antibiotics
    2. Antiviral
    3. Antiretroviral
    4. Others
  4. By Route of Administration
    1. Oral
    2. Parenteral
    3. Others
  5. By End User
    1. Hospitals
    2. Homecare
    3. Specialty Clinics
    4. Others
  6. By Region
    1. North America
    2. Europe
    3. Asia Pacific (APAC)
    4. Latin America (LATAM)
    5. Middle East and Africa (MEA)
North America Perinatal Infections Market
1. Market Size & Forecast, 2019–2029
  1. By Value (USD Million)
2. Market Share & Forecast
  1. By Infection
  2. By Diagnosis
  3. By Treatment
  4. By Route of Administration
  5. By End User
  6. By Country
    1. United States
      1. By Infection
      2. By Diagnosis
      3. By Treatment
      4. By Route of Administration
      5. By End User
    2. Canada
      1. By Infection
      2. By Diagnosis
      3. By Treatment
      4. By Route of Administration
      5. By End User
Europe Perinatal Infections Market
1. Market Size & Forecast, 2019–2029
  1. By Value (USD Million)
2. Market Share & Forecast
  1. By Infection
  2. By Diagnosis
  3. By Treatment
  4. By Route of Administration
  5. By End User
  6. By Country
    1. Germany
      1. By Infection
      2. By Diagnosis
      3. By Treatment
      4. By Route of Administration
      5. By End User
    2. UK
      1. By Infection
      2. By Diagnosis
      3. By Treatment
      4. By Route of Administration
      5. By End User
    3. Italy
      1. By Infection
      2. By Diagnosis
      3. By Treatment
      4. By Route of Administration
      5. By End User
    4. France
      1. By Infection
      2. By Diagnosis
      3. By Treatment
      4. By Route of Administration
      5. By End User
    5. Spain
      1. By Infection
      2. By Diagnosis
      3. By Treatment
      4. By Route of Administration
      5. By End User
    6. The Netherlands
      1. By Infection
      2. By Diagnosis
      3. By Treatment
      4. By Route of Administration
      5. By End User
    7. Rest of Europe
      1. By Infection
      2. By Diagnosis
      3. By Treatment
      4. By Route of Administration
      5. By End User
Asia-Pacific Perinatal Infections Market
1. Market Size & Forecast, 2019–2029
  1. By Value (USD Million)
2. Market Share & Forecast
  1. By Infection
  2. By Diagnosis
  3. By Treatment
  4. By Route of Administration
  5. By End User
  6. By Country
    1. China
      1. By Infection
      2. By Diagnosis
      3. By Treatment
      4. By Route of Administration
      5. By End User
    2. India
      1. By Infection
      2. By Diagnosis
      3. By Treatment
      4. By Route of Administration
      5. By End User
    3. Japan
      1. By Infection
      2. By Diagnosis
      3. By Treatment
      4. By Route of Administration
      5. By End User
    4. South Korea
      1. By Infection
      2. By Diagnosis
      3. By Treatment
      4. By Route of Administration
      5. By End User
    5. Australia & New Zealand
      1. By Infection
      2. By Diagnosis
      3. By Treatment
      4. By Route of Administration
      5. By End User
    6. Indonesia
      1. By Infection
      2. By Diagnosis
      3. By Treatment
      4. By Route of Administration
      5. By End User
    7. Malaysia
      1. By Infection
      2. By Diagnosis
      3. By Treatment
      4. By End User
    8. Singapore
      1. By Infection
      2. By Diagnosis
      3. By Treatment
      4. By Route of Administration
      5. By End User
    9. Philippines
      1. By Infection
      2. By Diagnosis
      3. By Treatment
      4. By Route of Administration
      5. By End User
    10. Vietnam
      1. By Infection
      2. By Diagnosis
      3. By Treatment
      4. By Route of Administration
      5. By End User
    11. Rest of APAC
      1. By Infection
      2. By Diagnosis
      3. By Treatment
      4. By Route of Administration
      5. By End User
Latin America Perinatal Infections Market
1. Market Size & Forecast, 2019–2029
  1. By Value (USD Million)
2. Market Share & Forecast
  1. By Infection
  2. By Diagnosis
  3. By Treatment
  4. By Route of Administration
  5. By End User
  6. By Country
    1. Brazil
      1. By Infection
      2. By Diagnosis
      3. By Treatment
      4. By Route of Administration
      5. By End User
    2. Mexico
      1. By Infection
      2. By Diagnosis
      3. By Treatment
      4. By Route of Administration
      5. By End User
    3. Argentina
      1. By Infection
      2. By Diagnosis
      3. By Treatment
      4. By Route of Administration
      5. By End User
    4. Peru
      1. By Infection
      2. By Diagnosis
      3. By Treatment
      4. By Route of Administration
      5. By End User
    5. Rest of LATAM
      1. By Infection
      2. By Diagnosis
      3. By Treatment
      4. By Route of Administration
      5. By End User
Middle East & Africa Perinatal Infections Market
1. Market Size & Forecast, 2019–2029
  1. By Value (USD Million)
2. Market Share & Forecast
  1. By Infection
  2. By Diagnosis
  3. By Treatment
  4. By Route of Administration
  5. By End User
  6. By Country
    1. Saudi Arabia
      1. By Infection
      2. By Diagnosis
      3. By Treatment
      4. By Route of Administration
      5. By End User
    2. UAE
      1. By Infection
      2. By Diagnosis
      3. By Treatment
      4. By Route of Administration
      5. By End User
    3. Qatar
      1. By Infection
      2. By Diagnosis
      3. By Treatment
      4. By Route of Administration
      5. By End User
    4. Kuwait
      1. By Infection
      2. By Diagnosis
      3. By Treatment
      4. By Route of Administration
      5. By End User
    5. South Africa
      1. By Infection
      2. By Diagnosis
      3. By Treatment
      4. By Route of Administration
      5. By End User
    6. Nigeria
      1. By Infection
      2. By Diagnosis
      3. By Treatment
      4. By Route of Administration
      5. By End User
    7. Algeria
      1. By Infection
      2. By Diagnosis
      3. By Treatment
      4. By Route of Administration
      5. By End User
    8. Rest of MEA
      1. By Infection
      2. By Diagnosis
      3. By Treatment
      4. By Route of Administration
      5. By End User
Competitive Landscape
1. List of Key Players and Their Offerings
2. Global Perinatal Infections Company Market Share Analysis, 2022
3. Competitive Benchmarking, By Operating Parameters
4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
Impact of Covid-19 on Global Perinatal Infections Market
Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
1. Merck KGaA
2. Beckman Coulter Inc.
3. BIOMERIEUX
4. Bio-Rad Laboratories, Inc
5. Danaher
6. Hologic Inc.
7. Gilead Sciences, Inc.
8. Emcure Pharmaceuticals Limited.
9. Cipla Inc.
10. Hetero
11. Bausch Health Companies Inc.
12. Johnson & Johnson Private Limited
13. Mylan N.V.
14. Teva Pharmaceutical Industries Ltd.
15. Sanofi
16. Novartis AG
17. Sun Pharmaceutical Industries Ltd.
18. Other Prominent Players
Key Strategic Recommendations
Research Methodology
1. Qualitative Research
  1. Primary & Secondary Research
2. Quantitative Research
3. Market Breakdown & Data Triangulation
  1. Secondary Research
  2. Primary Research
4. Breakdown of Primary Research Respondents, By Region
5. Assumptions & Limitations

*Financial information of case of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable

List of Figures

Figure 1 Global Perinatal Infections Segmentation

Figure 2 Global Perinatal Infections Market Value Chain Analysis

Figure 3 Company Market Share Analysis, 2022

Figure 4 Global Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 5 Global Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 6 Global Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 7 Global Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 8 Global Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 9 Global Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 10 Global Perinatal Infections Market Share, By Region, By Value, 2019–2029

Figure 11 North America Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 12 North America Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 13 North America Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 14 North America Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 15 North America Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 16 North America Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 17 North America Perinatal Infections Market Share, By Country, By Value, 2019–2029

Figure 18 United States Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 19 United States Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 20 United States Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 21 United States Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 22 United States Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 23 United States Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 24 Canada Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 25 Canada Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 26 Canada Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 27 Canada Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 28 Canada Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 29 Canada Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 30 Europe Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 31 Europe Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 32 Europe Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 33 Europe Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 34 Europe Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 35 Europe Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 36 Europe Perinatal Infections Market Share, By Country, By Value, 2019–2029

Figure 37 Germany Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 38 Germany Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 39 Germany Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 40 Germany Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 41 Germany Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 42 Germany Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 43 United Kingdom Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 44 United Kingdom Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 45 United Kingdom Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 46 United Kingdom Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 47 United Kingdom Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 48 United Kingdom Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 49 Italy Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 50 Italy Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 51 Italy Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 52 Italy Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 53 Italy Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 54 Italy Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 55 France Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 56 France Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 57 France Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 58 France Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 59 France Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 60 France Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 61 Spain Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 62 Spain Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 63 Spain Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 64 Spain Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 65 Spain Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 66 Spain Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 67 The Netherlands Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 68 The Netherlands Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 69 The Netherlands Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 70 The Netherlands Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 71 The Netherlands Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 72 The Netherlands Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 73 Rest of Europe Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 74 Rest of Europe Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 75 Rest of Europe Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 76 Rest of Europe Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 77 Rest of Europe Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 78 Rest of Europe Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 79 Asia-Pacific Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 80 Asia-Pacific Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 81 Asia-Pacific Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 82 Asia-Pacific Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 83 Asia-Pacific Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 84 Asia-Pacific Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 85 Asia-Pacific Perinatal Infections Market Share, By Country, By Value, 2019–2029

Figure 86 China Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 87 China Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 88 China Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 89 China Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 90 China Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 91 China Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 92 India Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 93 India Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 94 India Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 95 India Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 96 India Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 97 India Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 98 Japan Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 99 Japan Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 100 Japan Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 101 Japan Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 102 Japan Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 103 Japan Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 104 South Korea Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 105 South Korea Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 106 South Korea Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 107 South Korea Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 108 South Korea Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 109 South Korea Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 110 Australia & New Zealand Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 111 Australia & New Zealand Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 112 Australia & New Zealand Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 113 Australia & New Zealand Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 114 Australia & New Zealand Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 115 Australia & New Zealand Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 116 Indonesia Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 117 Indonesia Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 118 Indonesia Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 119 Indonesia Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 120 Indonesia Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 121 Indonesia Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 122 Malaysia Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 123 Malaysia Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 124 Malaysia Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 125 Malaysia Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 126 Malaysia Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 127 Malaysia Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 128 Singapore Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 129 Singapore Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 130 Singapore Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 131 Singapore Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 132 Singapore Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 133 Singapore Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 134 Philippines Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 135 Philippines Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 136 Philippines Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 137 Philippines Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 138 Philippines Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 139 Philippines Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 140 Vietnam Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 141 Vietnam Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 142 Vietnam Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 143 Vietnam Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 144 Vietnam Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 145 Vietnam Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 146 Rest of APAC Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 147 Rest of APAC Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 148 Rest of APAC Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 149 Rest of APAC Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 150 Rest of APAC Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 151 Rest of APAC Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 152 Latin America Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 153 Latin America Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 154 Latin America Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 155 Latin America Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 156 Latin America Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 157 Latin America Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 158 Latin America Perinatal Infections Market Share, By Country, By Value, 2019–2029

Figure 159 Brazil Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 160 Brazil Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 161 Brazil Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 162 Brazil Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 163 Brazil Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 164 Brazil Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 165 Mexico Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 166 Mexico Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 167 Mexico Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 168 Mexico Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 169 Mexico Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 170 Mexico Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 171 Argentina Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 172 Argentina Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 173 Argentina Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 174 Argentina Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 175 Argentina Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 176 Argentina Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 177 Peru Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 178 Peru Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 179 Peru Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 180 Peru Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 181 Peru Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 182 Peru Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 183 Rest of LATAM Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 184 Rest of LATAM Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 185 Rest of LATAM Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 186 Rest of LATAM Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 187 Rest of LATAM Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 188 Rest of LATAM Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 189 Middle East & Africa Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 190 Middle East & Africa Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 191 Middle East & Africa Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 192 Middle East & Africa Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 193 Middle East & Africa Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 194 Middle East & Africa Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 195 Middle East & Africa Perinatal Infections Market Share, By Country, By Value, 2019–2029

Figure 196 Saudi Arabia Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 197 Saudi Arabia Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 198 Saudi Arabia Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 199 Saudi Arabia Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 200 Saudi Arabia Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 201 Saudi Arabia Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 202 UAE Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 203 UAE Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 204 UAE Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 205 UAE Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 206 UAE Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 207 UAE Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 208 Qatar Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 209 Qatar Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 210 Qatar Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 211 Qatar Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 212 Qatar Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 213 Qatar Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 214 Kuwait Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 215 Kuwait Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 216 Kuwait Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 217 Kuwait Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 218 Kuwait Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 219 Kuwait Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 220 South Africa Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 221 South Africa Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 222 South Africa Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 223 South Africa Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 224 South Africa Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 225 South Africa Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 226 Nigeria Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 227 Nigeria Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 228 Nigeria Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 229 Nigeria Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 230 Nigeria Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 231 Nigeria Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 232 Algeria Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 233 Algeria Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 234 Algeria Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 235 Algeria Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 236 Algeria Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 237 Algeria Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 238 Rest of MEA Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 239 Rest of MEA Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 240 Rest of MEA Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 241 Rest of MEA Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 242 Rest of MEA Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 243 Rest of MEA Perinatal Infections Market Share, By End User, By Value, 2019–2029

List of Tables

Table 1 Global Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 2 Global Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 3 Global Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 4 Global Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 5 Global Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 6 Global Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 7 Global Perinatal Infections Market Size, By Region, By Value, 2019–2029

Table 8 North America Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 9 North America Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 10 North America Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 11 North America Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 12 North America Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 13 North America Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 14 North America Perinatal Infections Market Size, By Country, By Value, 2019–2029

Table 15 United States Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 16 United States Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 17 United States Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 18 United States Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 19 United States Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 20 United States Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 21 Canada Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 22 Canada Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 23 Canada Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 24 Canada Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 25 Canada Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 26 Canada Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 27 Europe Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 28 Europe Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 29 Europe Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 30 Europe Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 31 Europe Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 32 Europe Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 33 Europe Perinatal Infections Market Size, By Country, By Value, 2019–2029

Table 34 Germany Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 35 Germany Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 36 Germany Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 37 Germany Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 38 Germany Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 39 Germany Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 40 United Kingdom Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 41 United Kingdom Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 42 United Kingdom Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 43 United Kingdom Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 44 United Kingdom Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 45 United Kingdom Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 46 Italy Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 47 Italy Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 48 Italy Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 49 Italy Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 50 Italy Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 51 Italy Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 52 France Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 53 France Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 54 France Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 55 France Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 56 France Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 57 France Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 58 Spain Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 59 Spain Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 60 Spain Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 61 Spain Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 62 Spain Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 63 Spain Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 64 The Netherlands Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 65 The Netherlands Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 66 The Netherlands Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 67 The Netherlands Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 68 The Netherlands Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 69 The Netherlands Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 70 Rest of Europe Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 71 Rest of Europe Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 72 Rest of Europe Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 73 Rest of Europe Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 74 Rest of Europe Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 75 Rest of Europe Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 76 Asia-Pacific Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 77 Asia-Pacific Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 78 Asia-Pacific Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 79 Asia-Pacific Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 80 Asia-Pacific Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 81 Asia-Pacific Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 82 Asia-Pacific Perinatal Infections Market Size, By Country, By Value, 2019–2029

Table 83 China Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 84 China Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 85 China Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 86 China Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 87 China Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 88 China Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 89 India Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 90 India Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 91 India Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 92 India Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 93 India Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 94 India Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 95 Japan Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 96 Japan Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 97 Japan Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 98 Japan Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 99 Japan Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 100 Japan Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 101 South Korea Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 102 South Korea Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 103 South Korea Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 104 South Korea Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 105 South Korea Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 106 South Korea Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 107 Australia & New Zealand Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 108 Australia & New Zealand Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 109 Australia & New Zealand Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 110 Australia & New Zealand Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 111 Australia & New Zealand Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 112 Australia & New Zealand Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 113 Indonesia Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 114 Indonesia Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 115 Indonesia Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 116 Indonesia Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 117 Indonesia Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 118 Indonesia Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 119 Malaysia Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 120 Malaysia Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 121 Malaysia Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 122 Malaysia Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 123 Malaysia Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 124 Malaysia Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 125 Singapore Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 126 Singapore Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 127 Singapore Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 128 Singapore Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 129 Singapore Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 130 Singapore Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 131 Philippines Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 132 Philippines Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 133 Philippines Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 134 Philippines Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 135 Philippines Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 136 Philippines Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 137 Vietnam Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 138 Vietnam Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 139 Vietnam Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 140 Vietnam Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 141 Vietnam Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 142 Vietnam Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 143 Rest of APAC Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 144 Rest of APAC Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 145 Rest of APAC Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 146 Rest of APAC Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 147 Rest of APAC Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 148 Rest of APAC Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 149 Latin America Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 150 Latin America Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 151 Latin America Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 152 Latin America Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 153 Latin America Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 154 Latin America Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 155 Latin America Perinatal Infections Market Size, By Country, By Value, 2019–2029

Table 156 Brazil Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 157 Brazil Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 158 Brazil Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 159 Brazil Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 160 Brazil Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 161 Brazil Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 162 Mexico Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 163 Mexico Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 164 Mexico Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 165 Mexico Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 166 Mexico Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 167 Mexico Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 168 Argentina Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 169 Argentina Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 170 Argentina Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 171 Argentina Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 172 Argentina Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 173 Argentina Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 174 Peru Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 175 Peru Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 176 Peru Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 177 Peru Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 178 Peru Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 179 Peru Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 180 Rest of LATAM Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 181 Rest of LATAM Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 182 Rest of LATAM Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 183 Rest of LATAM Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 184 Rest of LATAM Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 185 Rest of LATAM Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 186 Middle East & Africa Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 187 Middle East & Africa Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 188 Middle East & Africa Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 189 Middle East & Africa Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 190 Middle East & Africa Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 191 Middle East & Africa Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 192 Middle East & Africa Perinatal Infections Market Size, By Country, By Value, 2019–2029

Table 193 Saudi Arabia Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 194 Saudi Arabia Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 195 Saudi Arabia Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 196 Saudi Arabia Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 197 Saudi Arabia Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 198 Saudi Arabia Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 199 UAE Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 200 UAE Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 201 UAE Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 202 UAE Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 203 UAE Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 204 UAE Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 205 Qatar Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 206 Qatar Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 207 Qatar Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 208 Qatar Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 209 Qatar Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 210 Qatar Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 211 Kuwait Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 212 Kuwait Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 213 Kuwait Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 214 Kuwait Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 215 Kuwait Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 216 Kuwait Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 217 South Africa Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 218 South Africa Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 219 South Africa Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 220 South Africa Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 221 South Africa Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 222 South Africa Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 223 Nigeria Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 224 Nigeria Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 225 Nigeria Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 226 Nigeria Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 227 Nigeria Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 228 Nigeria Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 229 Algeria Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 230 Algeria Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 231 Algeria Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 232 Algeria Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 233 Algeria Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 234 Algeria Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 235 Rest of MEA Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 236 Rest of MEA Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 237 Rest of MEA Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 238 Rest of MEA Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 239 Rest of MEA Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 240 Rest of MEA Perinatal Infections Market Share, By End User, By Value, 2019–2029

Table 241 ECOM Agroindustrial Corporation Ltd Company Overview

Table 242 ECOM Agroindustrial Corporation Ltd Financial Overview

Table 243 Merck KGaA Company Overview

Table 244 Merck KGaA Financial Overview

Table 245 Beckman Coulter Inc. Company Overview

Table 246 Beckman Coulter Inc. Financial Overview

Table 247 BIOMERIEUX Company Overview

Table 248 BIOMERIEUX Financial Overview

Table 249 Bio-Rad Laboratories, Inc Company Overview

Table 250 Bio-Rad Laboratories, Inc Financial Overview

Table 251 Danaher Company Overview

Table 252 Danaher Financial Overview

Table 253 Hologic Inc. Company Overview

Table 254 Hologic Inc. Financial Overview

Table 255 Gilead Sciences, Inc. Company Overview

Table 256 Gilead Sciences, Inc. Financial Overview

Table 257 Emcure Pharmaceuticals Limited. Company Overview

Table 258 Emcure Pharmaceuticals Limited. Financial Overview

Table 259 Cipla Inc. Company Overview

Table 260 Cipla Inc. Financial Overview

Table 261 Hetero Company Overview

Table 262 Hetero Financial Overview

Table 263 Bausch Health Companies Inc. Company Overview

Table 264 Bausch Health Companies Inc. Financial Overview

Table 265 Johnson & Johnson Private Limited Company Overview

Table 266 Johnson & Johnson Private Limited Financial Overview

Table 267 Mylan N.V. Company Overview

Table 268 Mylan N.V. Financial Overview

Table 269 Teva Pharmaceutical Industries Ltd. Company Overview

Table 270 Teva Pharmaceutical Industries Ltd. Financial Overview

Table 271 Sanofi Company Overview

Table 272 Sanofi Financial Overview

Table 273 Novartis AG Company Overview

Table 274 Novartis AG Financial Overview

Table 275 Sun Pharmaceutical Industries Ltd. Company Overview

Table 276 Sun Pharmaceutical Industries Ltd. Financial Overview

Market Segmentation

No data available

To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your exact research needs.

Yes, I have read the privacy policy

This website is secure and your personal details are safe.

Frequently Asked Questions (FAQs):

1. Which is the fastest growing region in Global Perinatal Infections Market?

Ans: Asia Pacific is expected to grow at the fastest rate in Global Perinatal Infections Market during the forecast period between 2023 and 2029.

2. What are the major factors driving the growth of Global Perinatal Infections Market?

Ans: Major factors driving the growth of Global Perinatal Infections Market include increased cases of HIV and increasing incidence of perinatal infections.

3. What is the expected growth rate of Global Perinatal Infections Market during the forecast period?

Ans: Global Perinatal Infections market is expected to grow at a CAGR of 7.30% during the forecast period between 2023 and 2029.

4. Name the key players in Global Perinatal Infections Market.

Ans: Key players in Global Perinatal Infections Market include Merck KGaA, Beckman Coulter Inc., BIOMERIEUX, Bio-Rad Laboratories, Inc, Danaher, Hologic Inc., Gilead Sciences, Inc., Emcure Pharmaceuticals Limited., Cipla Inc., Hetero, Bausch Health Companies Inc., Johnson & Johnson Private Limited, Mylan N.V., Teva Pharmaceutical Industries Ltd., Sanofi, Novartis AG, and Sun Pharmaceutical Industries Ltd.

5. Which segment accounted for the highest share in the Global Perinatal Infections Market by end user?

Ans: The hospitals segment held the highest Market share in the Global Perinatal Infections Market by end user.

PLACE AN ORDER

SINGLE USER LICENSE
$ 3637.5 ~~$ 4850~~
GROUP LICENSE
$ 4312.5 ~~$ 5750~~
ENTERPRISE LICENSE
$ 6112.5 ~~$ 8150~~
EXCEL DATA PACK
$ 2437.5 ~~$ 3250~~

ENQUIRE BEFORE PURCHASE

RELATED REPORTS

WHY CHOOSE US

24/7 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Coustom Research Service

Ask the Analyst to customize an exclusive study to serve your research needs
Quality & Accuracy

Ask the Analyst to customize an exclusive study to serve your research needs
Data Visualization

As the business world is changing dynamically every day. We need to stay pin point in relation to data management and optimum data utilization
Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.